San Diego-based CoDa Therapeutics, which is developing wound care therapies, garnered $10 million in its first round of venture capital. CoDa says it expects to add $5 million to $10 million more to that amount in the next 90 days. Much of that money will go to completing clinical trials.
"There is a tremendous market need for compounds like CoDa's, a topical, single application therapeutic that accelerates wound healing and reduces swelling, inflammation, and ultimate scar formation in numerous tissue types," stated James Mervis, chairman of CoDa Therapeutics and co-founder of Cardiokine.
- Here's the report from SoCalTech
ALSO: Achaogen has raised $26 million in its second round. Domain Associates led the round with participation from 5AM, Arch, Venrock and Versant. Report